Jan Rosenbaum, based in Cincinnati, OH, US, is currently a President, Chief Executive Officer, and CSO at Kurome Therapeutics, Inc., bringing experience from previous roles at Harrington Discovery Institute at University Hospitals, BRK-1 Technical Advisors, Inc., University of Cincinnati and Airway Therapeutics. Jan Rosenbaum holds a 1983 - 1986 Postdoctoral Fellow in Clinical Pharmacology @ Stanford University. With a robust skill set that includes Technical Due Diligence, Molecular Pharmacology, Patent Strategy, Signal Transduction, Life Sciences and more, Jan Rosenbaum contributes valuable insights to the industry. Jan Rosenbaum has 6 emails and 1 mobile phone number on RocketReach.